---
title: "Valaris Q1 Loss Narrows, Revenue Falls"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285123246.md"
description: "Valaris reported a Q1 loss of $0.24 per diluted share, an improvement from a loss of $0.53 a year prior. Revenue for the quarter was $465.4 million, down from $620.7 million the previous year. Analysts had expected a loss of $0.04 and revenue of $443.8 million."
datetime: "2026-05-04T20:44:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285123246.md)
  - [en](https://longbridge.com/en/news/285123246.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285123246.md)
---

# Valaris Q1 Loss Narrows, Revenue Falls

04:44 PM EDT, 05/04/2026 (MT Newswires) -- Valaris ( VAL ) on Monday reported Q1 loss of $0.24 per diluted share, narrowing from a loss of $0.53 a year earlier.

Analysts polled by FactSet expected a loss of $0.04.

Revenue for the quarter ended March 31 was $465.4 million, down from $620.7 million a year ago.

Analysts surveyed by FactSet expected $443.8 million.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [VAL.US](https://longbridge.com/en/quote/VAL.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)
- [VAL+.US](https://longbridge.com/en/quote/VAL+.US.md)

## Related News & Research

- [Valaris Reports First Quarter 2026 Results | VAL Stock News](https://longbridge.com/en/news/285114918.md)
- [Valaris Issues Fleet Status Report | VAL Stock News](https://longbridge.com/en/news/285115866.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Deepak Nitrite Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286980047.md)